There is increasing evidence that an imbalance between products of arachidonic acid metabolism (such as prostaglandins, prostacyclin and thromboxane A2) and lipid peroxidation products might have a role in the pathogenesis of preeclampsia. In order to study some of the changes taking place in pre-eclampsia, the plasma concentrations of essential fatty acids and lipid peroxidation products [measured as thiobarbituric-acid (TBA)-reactive substance] were evaluated in 25 patients with severe pre-eclampsia and 20 normal pregnant control subjects. Arachidonic acid concentration (median and range) was significantly higher in the pre-eclamptic group (14,1; 11·0 -19·8 Jig/L) compared with the normal pregnant subjects (2'5; 2·0-4-4Jig/L). Plasma concentration of TBA-reactive substance was also significantly higher in the pre-eclamptic cases (14'8; 13·4-16,8 vs 11-4; 9·0 -12,8). These results suggest that arachidonic acid and lipid peroxidation products may playa role in the pathogenesis of pre-eclampsia.
INTRODUCTION
Pregnancy-induced hypertension (PIH) and preeclampsia occur in 10% of pregnancies and are important sources of risk to both mother and foetus. The exact cause of pre-eclampsia is unknown. Enhanced sensitivity to vasopressors and imbalance in the production of prostaglandins are thought to playa role. These may lead to vasoconstriction of small arteries, platelet activation and utero-placental insufficiency.' Unsaturated fatty acids are substrate for lipid oxidation and they also take part in the formation of thromboxane. Pre-eclampsia is associated with platelet membrane damage with the release of unsaturated fatty acids and other products such as thromboxane, with subsequent imbalance of thromboxane A2/prostacyclin production. This may contribute to the onset and maintenance of vasoconstriction and hypertension.? Essential fatty acids (EFA) are important structural elements of cell membranes and foetal development is associated with high EFA requirement. 3 Correspondence: Dr Thanaa Abou Shouk.
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On the other hand, oxygen free radicals and lipid peroxides might form the link between the hypothetical immunologic maladaptation and the endothelial cell damage known to occur in pre-eclampsia. Some studies have demonstrated increased oxygen free radical production in preeclampsia." Uncontrolled lipid peroxidation may play an important role in the pathophysiology of pre-eclampsia by causing vascular endothelial cell dysfunction.l Pregnancy is known to cause an increase in lipid peroxidation products.?
In this study the plasma concentrations of polyunsaturated fatty acids and lipid peroxidation products were being estimated in severely pre-eclamptic patients and in normal pregnant subjects in order to evaluate their role in the pathophysiology of pre-eclampsia.
MATERIALS AND METHODS

Subjects
Twenty-five patients from Ain Shams University Maternity Hospital [mean age (SD): 29 (8'2) years; range: 20-40 years] suffering from severe pre-eclampsia in their third trimester were included in the present study. Twenty normal pregnant women (matched for age, parity and gestation) attending the antenatal clinic served as the control group. They were normotensive, without proteinuria or history of renal disease, were not on medications and did not have any obstetric complications.
After obtaining informed consent, a fasting blood sample (9 ml) was collected into plastic tubes containing I mL 3·2% sodium citrate. Plasma was obtained by centrifugation at 1500 g for 20 min at room temperature and stored at -20°C in small aliquots. Both control and patient samples were assayed under the same experimental conditions in one batch.
Procedures
Quantitation of plasma EFA Plasma fatty acids were first derivatized to their methyl esters as described by Lepage and Roy." Plasma (150 J.LL) was mixed with 5 mL methanol acetyl chloride (50/1 vlv) and incubated for 45 min at room temperature. One millilitre of hexane was added and the contents were mixed. The hexane layer was then aspirated, evaporated to dryness under a stream of nitrogen and the residue dissolved in a minimal volume of acetonitrile for injection into high-performance liquid chromatography (HPLC). The standards, methyl esters of linoleic (18:2 n-6), IX-linolenic (18:3 n-3), arachidonic (20:4 n-6), eicosapentaenoic (20:5 n-3) and docosahexaenoic (22:6 n-3) acids were purchased from Sigma (St Louis MO, USA). Twenty-five microlitres of extracts or standards were injected into a reverse phase C18 ultrosphere (25 x O' 5 cm). The mobile phase was methanol/water (85:15 v/v) at a flow rate of I mL/ min and absorbence was monitored at 2lOnm.
Quantitation of lipid peroxidation products
Lipid peroxidation products were measured in plasma using the modified thiobarbituric acid assay (TBA) method described by Draper and Hadley." To 0·5mL of plasma, 2'5mL of 10% trichloroacetic acid (TCA) solution was added and the mixture was placed in a boiling water bath for 15min. After cooling, the mixture was centrifuged at 1000g for 10min and 2mL of the supernatant was added to 1 mL of 0·67% TBA solution. The mixture was placed in a boiling water bath for 15 min. The solution was then cooled and absorbence measured at 532 nm. Concentration of the TBA-reactive substance was expressed in micromoles of malondialdehyde (MDA) per litre of plasma. Tetramethoxypropane was used as a standard.
Statistical analysis
As data were not normally distributed, differences between control and patient groups were examined by the Mann-Whitney U test. A P of < 0·05 was considered significant. Table I shows the median and range of essential fatty acids and TBA-reactive substance in the pre-eclamptic and control groups. The concentration of arachidonic acid was significantly higher in the pre-eclamptic group compared with the normal pregnant group. However, the other polyunsaturated fatty acids did not show any significant difference between the groups.
RESULTS
Lipid peroxidation product was significantly higher in the pre-eclamptic group compared with the normal pregnant group (see Table I ). There was no correlation between the increased concentration of arachidonic acid and TBAreactive substance.
DISCUSSION
In this study the concentration of arachidonic acid was found to be higher in pre-eclamptic patients and this may be due to increased phospholipase A 2 activity. Jendryczko et al. 8 have shown higher phospholipase A 2 activity in placental homogenates from patients with preeclampsia. The altered release of arachidonic acid may result in imbalance in the production of a number of pharmacologically active compounds, such as prostaglandins, prostacyclin and thromboxane A2, which are derived from arachidonic acid through the action of cyclooxygenase. This imbalance may result in endothelial cell dysfunction. Davidge et al. 9 concluded that changes in prostanoid activity in systemic vasculature during pregnancy may be mediated by concerted induction and downregulation of specific enzymes. They also concluded that the increased lipid peroxidation interferes with this normal pregnancy pattern. Low-dose aspirin selectively inhibits the synthesis of platelet thromboxane A2 without affecting the production of endothelium-derived prostacyclin.' The data from clinical trials suggest that when low-dose aspirin is given to high-risk patients the risk of pre-eclampsia and intra-uterine growth retardation was reduced by 50%, with no observed risk to either mother or foetus. 1 We found that the concentration of plasma TBA-reactive substance concentration was significantly higher in pre-eclampsia. This finding agrees with the observations of Sane et al. 1O who showed that the concentrations of lipoperoxides were higher in pre-eclampsia. The results also agree with those previously obtained by Davidge et al., 4 who reported that pre delivery serum samples from women with pre-eclampsia had one-half the antioxidant activity of serum samples from women with uncomplicated pregnancies. This reduced antioxidant activity may result in a greater potential for oxidative endothelial damage.
Oxygen free radicals and lipid peroxides might form the link between hypothetical immunologic adaptation and the endothelial cell damage known to occur in pre-eclampsia.'! Uotila et al. 12 suggested that lipid peroxidation is involved in the pathogenesis of PIH and may also have an effect on the vascular function and antioxidant status of mother and foetus. Jain and Wise l3 reported an increased concentration of MDA in pre-eclampsia and suggested a relationship between increased lipid peroxidation, lower vitamin K concentration and hypertension in pre-eclampsia. Du et al. 14 concluded that the decrease in red cell deformability due to the increase in plasma MDA concentration may be the underlying mechanism ofPIH. Hubel et alY reported that triacylglycerols and free fatty acids, but not cholesterol, are increased in pre-eclampsia and correlate with the lipid peroxidation metabolite malondialdehyde. They concluded that these interactions may contribute to endothelial cell dysfunction in pre-eclampsia.
In conclusion, our results suggest that arachidonic acid and lipid peroxidation products may have a role in the pathophysiology of preeclampsia. Further evaluation of the different enzymes involved in the arachidonic acid metabolic pathways is required.
